Looks like you're in the United States. Switch to the United States site for products available in your region.
帖子
taishiro
查看原文
However, the market needs to separate what has been announced from what has been delivered. HIP 3 remains in the testnet phase, and regulatory approval for US operations is still outstanding.
From a market perspective, the long-term opportunity is credible, but execution will determine whether it translates into lasting value for HYPE holders.
I would prioritize confirmed adoption and regulatory progress over chasing short-term price momentum.